![]() |
市場調查報告書
商品編碼
1504230
體外受精的市場規模,佔有率,預測,趨勢分析:各類型,各產品,週期,各用途,各終端用戶-2031年為止的世界預測In Vitro Fertilization Market Size, Share, Forecast, & Trends Analysis by Type (Natural, Intracytoplasmic, Minimal), Product (Imaging, Cryosystems, IVF Cabinets, Incubator, Media, Sperm Analyzer), Cycle, Application, End User - Global Forecast to 2031 |
體外受精 (IVF) 市場預計到 2031 年將達到 42 億美元,2024 年至 2031 年複合年增長率為 7.1%。
該報告經過廣泛的二級和一級研究以及對市場情景的詳細分析,對關鍵行業驅動因素、市場限制、機會和課題進行了分析。 IVF市場的成長主要是由於不孕率上升、IVF程序技術進步、IVF懷孕成功率高、社會文化規範變化、有利的政府法規和政策以及IVF成本降低所推動。然而,與體外受精治療相關的健康風險和併發症(例如卵巢過度刺激綜合徵和多胎妊娠)以及週期不成功的風險正在限制該市場的成長。
此外,增加用於選擇最佳胚胎的植入前基因測試(PGT)的機會預計將為 IVF 市場的參與者提供成長機會。然而,專門的試管嬰兒診所數量有限,特別是在農村地區,以及透過試管嬰兒出生的嬰兒有先天畸形的風險是試管嬰兒市場的主要課題。此外,選擇性卵子冷凍、選擇性單一胚胎移植以及人工智慧在體外受精治療中的整合是體外受精市場的顯著趨勢。
(*註:為前 5 名公司提供 SWOT 分析)
The In Vitro Fertilization (IVF) market is projected to reach $4.20 billion by 2031 at a CAGR of 7.1% from 2024 to 2031.
After extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges. The growth of the IVF market is primarily driven by increasing infertility rates, technological advancements in IVF procedures, the high success rates of pregnancy through IVF, changing socio-cultural norms, favorable government regulations & policies, and the reducing costs of IVF. However, the health risks & complications associated with IVF treatment, such as ovarian hyperstimulation syndrome and multiple pregnancies, and the risk of unsuccessful cycles restrain the growth of this market.
Furthermore, the increasing access to Preimplantation Genetic Testing (PGT) for selecting the best embryos is expected to offer growth opportunities for the players operating in the IVF market. However, the limited availability of specialized IVF clinics, especially in rural areas, and the risk of birth defects in babies born through IVF are major challenges in the IVF market. Additionally, elective egg freezing, elective single-embryo transfers, and the integration of AI in IVF treatment are prominent trends in the IVF market.
The report offers a competitive landscape based on an extensive assessment of the leading players' product portfolios, geographic presence, and key strategies adopted over the last four years (2020-2024). The key players operating in the in vitro fertilization market are Esco Micro Pte. Ltd. (Singapore), Vitrolife Sweden AB (Sweden), Thermo Fisher Scientific Inc. (U.S.), Rocket Medical plc (U.K.), Kitazato Corporation (Japan), CooperSurgical, Inc. (U.S.), FUJIFILM Irvine Scientific. (U.S.), Hamilton Thorne Inc. (U.S.), Carl Zeiss AG (Germany), FERTIPRO NV (Belgium), and The Baker Company (U.S.).
Among all the products studied in this report, in 2024, the instruments segment is expected to account for the largest share of 62.9% of the in vitro fertilization market. The instruments segment is further categorized into imaging systems, ovum aspiration pumps, micromanipulator systems, gas analyzers, incubators, laser analyzers, cryosystems, sperm separation devices, sperm analyzer systems, sterile cabinets, and other instruments. The rising demand for advanced IVF instruments, high affordability in the private sector, the increasing number of fertility clinics, and rising healthcare expenditures support the segment's large market share.
Among all the applications studied in this report, in 2024, the human reproduction segment is expected to account for the major share of the in vitro fertilization market. The segment's large share is attributed to the increasing demand for IVF due to increasing pregnancy success rates through IVF, rising healthcare expenditures, the increasing demand for IVF due to changing socio-demographic trends, the availability of modern technologies, and decreasing natural fertility rates. For instance, according to the World Health Organization's April 2023 Report, 1 in 6 people globally are affected by infertility.
Based on end user, the IVF market is segmented into hospitals, fertility clinics, research institutes, and cryobanks. In 2024, the fertility clinics segment is expected to account for the largest share of the in vitro fertilization market. The large share of this segment is attributed to the increased adoption of advanced techniques in fertility clinics for the treatment of infertility. Additionally, fertility clinics have specialized expertise and also offer a comprehensive range of services beyond IVF, including counseling and egg freezing. The rising demand for IVF treatments and the increasing number of IVF clinics worldwide are further supporting the segment's large share. For instance, according to the National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health (U.S.), there are approximately 500 fertility clinics in the U.S.
An in-depth analysis of the geographical scenario of the global IVF market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of 42.0% of the in vitro fertilization market. North America's large market share is attributed to the availability of advanced infrastructure, high healthcare expenditures, favorable policies, and the presence of key players with well-established distribution channels in the region. However, Asia-Pacific is expected to register the highest CAGR of 9.4% during the forecast period due to the growing number of individuals with infertility, changing socio-cultural norms, increasing healthcare expenditures, and increasing access to fertility clinics in the region.
In Vitro Fertilization Market Assessment-by Product
Note: Other Instruments include anti-vibration tables, air purification systems, witness systems, glass heaters, and tube warmers.
Note: Other accessories include dishes, pipettes, tubes, sperm-counting chambers, shelves, and microscope slides.
In Vitro Fertilization Market Assessment-by Type
Note: Other types include needle-free IVF, ovarian rejuvenation therapy, and egg freezing.
In Vitro Fertilization Market Assessment-by Cycle
In Vitro Fertilization Market Assessment-by Application
In Vitro Fertilization Market Assessment-by End User
In Vitro Fertilization Market Assessment-by Geography
(*Note: SWOT analysis will be provided for the top 5 companies.)